These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 31150957)

  • 21. Using machine learning to quantify structural MRI neurodegeneration patterns of Alzheimer's disease into dementia score: Independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases.
    Popuri K; Ma D; Wang L; Beg MF
    Hum Brain Mapp; 2020 Oct; 41(14):4127-4147. PubMed ID: 32614505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-trained MRI-based Alzheimer's disease classification models to classify memory clinic patients.
    de Vos F; Schouten TM; Koini M; Bouts MJRJ; Feis RA; Lechner A; Schmidt R; van Buchem MA; Verhey FRJ; Olde Rikkert MGM; Scheltens P; de Rooij M; van der Grond J; Rombouts SARB
    Neuroimage Clin; 2020; 27():102303. PubMed ID: 32554321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarker Extraction Based on Subspace Learning for the Prediction of Mild Cognitive Impairment Conversion.
    Li Y; Fang Y; Wang J; Zhang H; Hu B
    Biomed Res Int; 2021; 2021():5531940. PubMed ID: 34513992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal changes in microstructural white matter metrics in Alzheimer's disease.
    Mayo CD; Mazerolle EL; Ritchie L; Fisk JD; Gawryluk JR;
    Neuroimage Clin; 2017; 13():330-338. PubMed ID: 28066707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural neuroimaging changes associated with subjective cognitive decline from a clinical sample.
    Riverol M; Ríos-Rivera MM; Imaz-Aguayo L; Solis-Barquero SM; Arrondo C; Montoya-Murillo G; Villino-Rodríguez R; García-Eulate R; Domínguez P; Fernández-Seara MA
    Neuroimage Clin; 2024; 42():103615. PubMed ID: 38749146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
    Beheshti I; Demirel H; Matsuda H;
    Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.
    Massetti N; Russo M; Franciotti R; Nardini D; Mandolini GM; Granzotto A; Bomba M; Delli Pizzi S; Mosca A; Scherer R; Onofrj M; Sensi SL; ;
    J Alzheimers Dis; 2022; 85(4):1639-1655. PubMed ID: 34958014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated classification of Alzheimer's disease, mild cognitive impairment, and cognitively normal patients using 3D convolutional neural network and radiomic features from T1-weighted brain MRI: A comparative study on detection accuracy.
    Zarei A; Keshavarz A; Jafari E; Nemati R; Farhadi A; Gholamrezanezhad A; Rostami H; Assadi M
    Clin Imaging; 2024 Nov; 115():110301. PubMed ID: 39303405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
    Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
    Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1.
    Wang Q; Guo L; Thompson PM; Jack CR; Dodge H; Zhan L; Zhou J;
    J Alzheimers Dis; 2018; 64(1):149-169. PubMed ID: 29865049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
    Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
    Elife; 2023 Jan; 12():. PubMed ID: 36607335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease.
    Liu M; Li F; Yan H; Wang K; Ma Y; ; Shen L; Xu M
    Neuroimage; 2020 Mar; 208():116459. PubMed ID: 31837471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ensemble of random forests One vs. Rest classifiers for MCI and AD prediction using ANOVA cortical and subcortical feature selection and partial least squares.
    Ramírez J; Górriz JM; Ortiz A; Martínez-Murcia FJ; Segovia F; Salas-Gonzalez D; Castillo-Barnes D; Illán IA; Puntonet CG;
    J Neurosci Methods; 2018 May; 302():47-57. PubMed ID: 29242123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. White matter structure and derived network properties are used to predict the progression from mild cognitive impairment of older adults to Alzheimer's disease.
    Jiaxuan Peng ; Zheng G; Hu M; Zhang Z; Yuan Z; Xu Y; Shao Y; Zhang Y; Sun X; Han L; Gu X; Zhenyu Shu ;
    BMC Geriatr; 2024 Aug; 24(1):691. PubMed ID: 39160467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau.
    Dickerson BC; Wolk DA;
    Front Aging Neurosci; 2013; 5():55. PubMed ID: 24130528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Efficient Combination among sMRI, CSF, Cognitive Score, and
    Khatri U; Kwon GR
    Comput Intell Neurosci; 2020; 2020():8015156. PubMed ID: 32565773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodal imaging improves brain age prediction and reveals distinct abnormalities in patients with psychiatric and neurological disorders.
    Rokicki J; Wolfers T; Nordhøy W; Tesli N; Quintana DS; Alnaes D; Richard G; de Lange AG; Lund MJ; Norbom L; Agartz I; Melle I; Naerland T; Selbaek G; Persson K; Nordvik JE; Schwarz E; Andreassen OA; Kaufmann T; Westlye LT
    Hum Brain Mapp; 2021 Apr; 42(6):1714-1726. PubMed ID: 33340180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the progression of mild cognitive impairment to Alzheimer's disease by longitudinal magnetic resonance imaging-based dictionary learning.
    Lin Y; Huang K; Xu H; Qiao Z; Cai S; Wang Y; Huang L;
    Clin Neurophysiol; 2020 Oct; 131(10):2429-2439. PubMed ID: 32829290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding.
    Stonnington CM; Wu J; Zhang J; Shi J; Bauer Iii RJ; Devadas V; Su Y; Locke DEC; Reiman EM; Caselli RJ; Chen K; Wang Y;
    J Alzheimers Dis; 2021; 81(1):209-220. PubMed ID: 33749642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.